Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 41 | 80 | 73 | 53 | 66 | 83 | 37 | 33 | 64 | 49 | 46 | 82 | |||||
Debt Securities Current | 338 | 318 | 279 | 262 | 246 | 275 | 312 | 297 | 255 | 302 | 292 | 269 | |||||
Accounts And Other Receivables Net Current | 49 | 41 | 31 | 40 | 40 | 37 | 36 | 26 | 29 | 24 | 38 | 19 | |||||
Inventory Net | 46 | 46 | 45 | 47 | 46 | 39 | 39 | 39 | 40 | 40 | 33 | 33 | |||||
Prepaid Expense Current | - | - | - | - | - | - | - | 8 | 8 | 9 | 16 | 11 | |||||
Other Assets Current | 2 | 1 | 0 | 1 | 1 | 1 | 3 | 7 | 2 | 1 | 2 | 1 | |||||
Assets Current | 480 | 492 | 439 | 409 | 406 | 447 | 440 | 410 | 398 | 425 | 426 | 416 | |||||
Assets Noncurrent | |||||||||||||||||
Deferred Income Tax Assets Net | 167 | 176 | - | - | - | 0 | - | - | - | - | - | - | |||||
Finance Lease Right Of Use Asset | 70 | 74 | 79 | 83 | 88 | 92 | 96 | 101 | 104 | 109 | 113 | 117 | |||||
Finite Lived Intangible Assets Net | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | |||||
Operating Lease Right Of Use Asset | 2 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | |||||
Property Plant And Equipment Net | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | |||||
Debt Securities Noncurrent | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 | - | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | |||||
Assets | 724 | 752 | 528 | 503 | 505 | 551 | 549 | 524 | 517 | 548 | 555 | 549 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Liabilities | |||||||||||||||||
Accounts Payable And Accrued Liabilities Current | - | - | - | - | - | - | 57 | 56 | 50 | 54 | 52 | 41 | |||||
Accounts Payable Current | 3 | 3 | 2 | 3 | 4 | 5 | - | - | - | 4 | - | - | |||||
Accrued Liabilities Current | 58 | 67 | 50 | 50 | 42 | 65 | - | - | - | 50 | - | - | |||||
Finance Lease Liability Current | 17 | 17 | 16 | 16 | 15 | 14 | 15 | 14 | 14 | 15 | 13 | 14 | |||||
Contract With Customer Liability Current | 5 | 4 | 5 | 5 | 5 | 11 | 4 | 4 | 5 | 5 | 5 | 3 | |||||
Operating Lease Liability Current | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Other Liabilities Current | 3 | 2 | 3 | 3 | 2 | 2 | 2 | 1 | 1 | 2 | 3 | 2 | |||||
Liabilities Current | 87 | 94 | 76 | 78 | 68 | 98 | 79 | 77 | 71 | 77 | 74 | 62 | |||||
Liabilities Noncurrent | |||||||||||||||||
Finance Lease Liability Noncurrent | 48 | 52 | 56 | 59 | 57 | 59 | 66 | 65 | 67 | 75 | 72 | 79 | |||||
Other Liabilities Noncurrent | - | 7 | - | - | - | 9 | 11 | 11 | 12 | 11 | 10 | 9 | |||||
Contract With Customer Liability Noncurrent | - | 13 | - | - | - | 2 | - | - | - | - | - | - | |||||
Deferred Revenue Noncurrent | 12 | - | 12 | 12 | 12 | - | - | - | - | - | - | - | |||||
Operating Lease Liability Noncurrent | 2 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | |||||
Liabilities | 156 | 170 | 162 | 167 | 155 | 173 | 161 | 159 | 157 | 170 | 163 | 157 | |||||
Stockholders Equity Inclu… | |||||||||||||||||
Common Stock Value Outstanding | 1,087 | 1,120 | 1,117 | 1,123 | 1,163 | 1,188 | 1,207 | 1,206 | 1,208 | 1,200 | 1,199 | 1,196 | |||||
Additional Paid In Capital Common Stock | 97 | 111 | 110 | 105 | 101 | 127 | 120 | 112 | 105 | 121 | 110 | 99 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -1 | -1 | -1 | -1 | -1 | -1 | -0 | -1 | -1 | -1 | -1 | -1 | |||||
Retained Earnings Accumulated Deficit | -615 | -649 | -860 | -892 | -913 | -937 | -938 | -952 | -953 | -942 | -915 | -902 | |||||
Stockholders Equity | 568 | 581 | 366 | 335 | 350 | 377 | 388 | 365 | 359 | 378 | 392 | 392 | |||||
Liabilities And Stockholders Equity | 724 | 752 | 528 | 503 | 505 | 551 | 549 | 524 | 517 | 548 | 555 | 549 | |||||
Related Party | - | - | - | - | - | 0 | 0 | 0 | 1 | 1 | - | - | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Issued | 131 | 132 | 132 | 133 | 138 | 141 | 143 | 143 | 144 | 144 | 144 | 143 | |||||
Shares Outstanding | 131 | 132 | 132 | 133 | 138 | 141 | 143 | 143 | 144 | 144 | 144 | 143 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.25% | 13.80% | 1.39% | - | - | - | - | - | - | - | - | - |
| 2025 | 0.86% | -6.53% | 29.19% | 32.72% | 40.62% | 24.93% | 12.96% | 13.88% | 1.82% | 0.36% | 14.89% | 9.38% |
| 2024 | 0.77% | 6.96% | 7.54% | 20.50% | 28.34% | 25.31% | 6.24% | 10.31% | -4.08% | 11.79% | 2.65% | 8.48% |
| 2023 | - | - | - | -13.26% | -20.93% | -28.98% | 16.37% | 16.75% | 1.52% | -9.80% | -16.11% | -15.28% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 5.55 | 5.25 | 5.76 | 5.23 | 5.93 | 4.57 | 5.60 | 5.33 | 5.60 | 5.50 | 5.77 | 6.75 | |||||
| Quick Ratio | 5.01 | 4.76 | 5.17 | 4.63 | 5.26 | 4.17 | 5.11 | 4.72 | 4.94 | 4.87 | 5.11 | 6.02 | |||||
| Working Capital | 393.69M | 398.24M | 362.52M | 330.70M | 337.36M | 348.83M | 361.85M | 332.76M | 327.17M | 347.61M | 352.58M | 354.25M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.28 | 0.29 | 0.44 | 0.50 | 0.44 | 0.46 | 0.42 | 0.44 | 0.44 | 0.45 | 0.42 | 0.40 | |||||
| Interest Coverage TTM | 29.12 | 24.23 | 15.81 | 11.46 | 6.58 | -0.97 | -6.54 | -11.69 | -18.57 | -13.92 | -11.01 | -10.10 | |||||
| Debt Ratio | 0.22 | 0.23 | 0.31 | 0.33 | 0.31 | 0.31 | 0.29 | 0.30 | 0.30 | 0.31 | 0.29 | 0.29 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.49 | 0.43 | 0.49 | 0.51 | 0.48 | 0.43 | 0.40 | 0.39 | 0.40 | 0.34 | 0.30 | 0.31 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 2.17 | 2.07 | 0.57 | 0.44 | 0.28 | 0.04 | -0.15 | -0.35 | -0.43 | -0.54 | -0.54 | -0.51 | |||||
| Free Cash Flow Per Share TTM | 1.26 | 1.01 | 0.91 | 0.69 | 0.46 | 0.31 | 0.20 | -0.01 | -0.14 | -0.24 | -0.26 | -0.28 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 89.74% | 88.46% | 88.93% | 89.51% | 88.24% | 87.99% | 87.25% | 86.08% | 88.78% | 91.94% | 93.63% | 96.38% | |||||
| Operating Profit Margin TTM | 41.73% | 37.06% | 26.34% | 19.99% | 12.30% | -1.99% | -14.84% | -29.31% | -39.37% | -52.24% | -56.73% | -52.06% | |||||
| Net Profit Margin TTM | 99.97% | 101.47% | 29.28% | 23.31% | 16.11% | 2.45% | -10.23% | -24.31% | -32.69% | -44.45% | -48.59% | -45.42% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 20.62% | 20.38% | 20.62% | 25.59% | 29.20% | 33.97% | 38.72% | 29.35% | 30.37% | 30.95% | 23.14% | 82.19% | |||||
| Net Income Growth (1Y) | 648.43% | 4,893.08% | -445.14% | -220.43% | -163.69% | -107.37% | -70.78% | -30.78% | -35.34% | -27.88% | -33.14% | -53.59% | |||||
| EPS Growth (1Y) | 685.42% | 5,216.00% | -474.58% | -227.98% | -166.02% | -107.38% | -70.83% | -31.04% | -35.96% | -28.54% | -33.61% | -53.93% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 6.58 | 7.46 | 18.71 | 18.84 | 28.03 | 223.34 | -46.50 | -16.25 | -11.53 | -16.50 | -14.38 | -19.00 | |||||
| P/B TTM | 3.46 | 3.69 | 3.98 | 3.41 | 3.19 | 3.40 | 2.70 | 2.24 | 2.01 | 3.41 | 2.83 | 3.52 | |||||
| P/S TTM | 6.58 | 7.57 | 5.48 | 4.39 | 4.52 | 5.46 | 4.76 | 3.95 | 3.77 | 7.34 | 6.99 | 8.63 | |||||
| Market Cap | 1.96B | 2.14B | 1.46B | 1.14B | 1.12B | 1.28B | 1.05B | 818.40M | 721.51M | 1.29B | 1.11B | 1.38B | |||||
| Enterprise Value | 1.99B | 2.13B | 1.46B | 1.16B | 1.12B | 1.27B | 1.09B | 863.82M | 738.79M | 1.33B | 1.15B | 1.39B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 166.92M | 135.66M | 120.10M | 92.56M | 64.07M | 44.16M | 28.36M | -1.84M | -20.48M | -33.70M | -37.56M | -39.62M | |||||
| Net Debt | 23.69M | -11.37M | -1.15M | 22.45M | 4.91M | -10.83M | 43.74M | 45.42M | 17.29M | 41.21M | 39.12M | 11.73M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Aurinia Pharmaceuticals Inc. (AUPH) — SEC Financial Statements & Analysis
Aurinia Pharmaceuticals Inc. (AUPH) is a pharmaceutical preparations company. Aurinia Pharmaceuticals Inc. trades on AUPH: Nasdaq as: AUPH. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Aurinia Pharmaceuticals Inc. reported a 20.62% year-over-year revenue growth, a Gross Profit Margin of 89.74% (TTM), a Debt-to-Equity ratio of 0.28x, a Price-to-Sales (P/S) ratio of 6.58x (TTM), a Price-to-Book (P/B) ratio of 3.46 (TTM), at a market cap of $1.96B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 20.62%
- Gross Profit Margin TTM
- 89.74%
- Debt To Equity
- 0.28x
- P/S TTM
- 6.58x
- P/B TTM
- 3.46
- Market Cap
- $1.96B
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Aurinia Pharmaceuticals Inc. in?
Aurinia Pharmaceuticals Inc. (AUPH) operates in the Pharmaceutical Preparations industry.
What is AUPH's market cap?
Aurinia Pharmaceuticals Inc. (AUPH) has a market capitalization of $1.96B as of 2026-03-31.
What is AUPH's P/E ratio?
Aurinia Pharmaceuticals Inc. (AUPH)'s trailing twelve month P/E ratio is 6.58x as of 2026-03-31.
What exchange does AUPH trade on?
Aurinia Pharmaceuticals Inc. (AUPH) trades on the AUPH: Nasdaq.